OPDP Researchers Will Conduct Tradeoff Analysis of Product Claims Made to Consumers and Physicians

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

OPDP Researchers Will Conduct Tradeoff Analysis of Product Claims Made to Consumers and Physicians

J.W. Schomisch

April 29, 2022 at 11:38 AM EST

Researchers with the Office of Prescription Drug Promotion (OPDP) plan to conduct a tradeoff analysis of prescription drug product claims in Direct-to-Consumer (DTC) and healthcare provider promotion. “The proposed research examines the relative importance of prescription drug product information such as prescription drug efficacy, risk, adherence, and patient preference clai... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

OPDP Researchers Will Conduct Tradeoff Analysis of Product Claims Made to Consumers and Physicians

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT